drugset / Trial / NCT06929260

A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z

NCT06929260

Phase 1 Terminated 1 enrolled AstraZeneca Parexel · collab
NaSingle-groupOpen-labelTreatment

Summary

The study aims to assess the effect of ceralasertib on the pharmacokinetics (PK) of Drug X, Drug Y and Drug Z in participants with advanced solid tumours.

Timeline

Start
2025-05-21
Primary completion
2025-10-15
Completion
2025-12-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceralasertib Small molecule
Subject Drug X Unknown
Subject Drug Y Unknown
Subject Drug Z Unknown

Indications